Videos Library

What is the Future for International Reference Pricing (IRP)

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific)

This free video is available for registered users


Most developed countries apply some form of IRP as a factor in negotiating or regulating domestic pricing. With the emergence of risk sharing agreements and in particular confidential price / volume agreements tied to HTA assessments some experts are suggesting the end of IRP systems in imminent. In contrast, some countries like Canada are placing greater reliance on IRP to lower drug prices.

  • Beginnings and Evolution of IRP.
  • Overview of approaches to IRP.
  • Impact of IRP on product launches and HTA.
  • Role of risk-sharing agreements to mitigate impact of IRP.
  • Canadian IRP as a case study.

Neil Palmer
Founder & Senior Consultant
PDCI Market Access


Subscribe or unlock this video to download the presentation slides. If you already have an account, please log in.


This is the presenters’ personal opinion and does not necessarily represent true facts, the official views or policy of their organisation, nor the views of NextLevel Life Sciences.